rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Sana Biotechnology, Inc.

SANA · Nasdaq

Health CareBiotechnologyNot moving yetSynthetic Biology / TechBio

SANA stood above a rising 150-day average in 16 of the last 52 weekly readings, and has been out of that trend for the last 33 weeks. It is 29.6% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 33
Industry in uptrend
16% -15 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
204 (+11)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.

20 Apr – 19 Oct
17%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1.8M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders204+11 on the quarter
New · exited36 · 23
Reported value$647.0M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCreduced · filed 13 Aug 202637,429,515$130.6M-7690.0%
Flagship Pioneering, LLCunchanged · filed 14 Aug 202625,001,856$87.3M00.0%
RA CAPITAL MANAGEMENT, L.P.new · filed 14 Aug 202618,750,000$65.4M+18,750,000
BlackRock, Inc.added · filed 7 Aug 202616,675,173$58.2M+2,434,998+17.1%
STATE STREET CORPadded · filed 7 Aug 202611,203,134$39.1M+665,048+6.3%
CANADA PENSION PLAN INVESTMENT BOARDreduced · filed 14 Aug 202610,218,400$35.7M-3,5000.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20268,375,421$29.2M+940,697+12.7%
BANK OF AMERICA CORPadded · filed 14 Aug 20265,748,454$20.1M+2,801,593+95.1%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20264,677,959$16.3M+495,986+11.9%
Marex Group Ltdreduced · filed 14 Aug 20263,989,100$13.9M-10,000−0.3%
31 Mar 2023 – 30 Jun 2026
100150200Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Hans Edgar Bishop Company insiderDirector · last 5 Oct 20260 · 0
Dhavalkumar Dhirajlal Patel Company insiderEVP, Chief Scientific Officer · last 27 Aug 20260 · 0
Alise Reicin Company insiderDirector · last 4 Jun 20260 · 0
Joshua H. Bilenker Company insiderDirector · last 4 Jun 20261 · 0
Michelle Seitz Company insiderDirector · last 4 Jun 20260 · 0
Patrick Y. Yang Company insiderDirector · last 4 Jun 20261 · 1
Richard Mulligan Company insiderDirector · last 4 Jun 20260 · 2
Robert L. Rosiello Company insiderDirector · last 4 Jun 20260 · 0
Robert Nelsen Company insiderDirector, 10% owner · last 4 Jun 20261 · 0
Steve Harr Company insiderPresident & CEO · last 9 Mar 20260 · 0
Susan D. Wyrick Company insiderOfficer · last 9 Mar 20260 · 0
Brian Piper Company insiderEVP, Chief Financial Officer · last 17 Feb 20260 · 0

Same industry

MRNA ModernaLeading+154%
ENTX Entera BioLeading+49%
XNCR XencorLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-74.0%
Share count trendFY 2025 · to 24 Feb 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$71.9M
Free cash flowFY 2025 · to 31 Dec 2025−$144.8M

Analyst forecasts

No analyst forecasts yet.